4//SEC Filing
BARRIER THERAPEUTICS INC 4
Accession 0001209191-08-045402
CIK 0001173657operating
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 3:19 PM ET
Size
7.8 KB
Accession
0001209191-08-045402
Insider Transaction Report
Form 4
Stiefel Charles W
Other
Transactions
- Purchase
Common Stock
2008-08-05$4.15/sh+34,266,494$142,205,950→ 34,266,494 total(indirect: See note)
Transactions
- Purchase
Common Stock
2008-08-05$4.15/sh+34,266,494$142,205,950→ 34,266,494 total(indirect: See note)
Footnotes (2)
- [F1]On August 5, 2008, upon the consummation of a cash tender offer and pursuant to the terms of an Agreement and Plan of Merger, dated as of June 23, 2008, by and between Stiefel Laboratories, Inc. ("Stiefel"), Bengal Acquisition Inc., a wholly-owned subsidiary of Stiefel ("Bengal"), and Barrier Therapeutics, Inc. (the "Issuer"), Bengal purchased 34,266,494 shares of the common stock, par value $0.0001 per share (the "Common Stock") of the Issuer, at a price of $4.15 per share.
- [F2]Charles W. Stiefel is the Chairman of the Board and Chief Executive Officer of Stiefel. Charles W. Stiefel, through his direct ownership of a majority of outstanding Class B shares of Stiefel (the Class B shares are entitled to elect a majority of the board of directors of Stiefel), and his ability pursuant to certain other arrangements to direct the voting of certain additional Class A and Class B shares of Stiefel, may be deemed to control Stiefel. As a result, Charles W. Stiefel may be deemed to share beneficial ownership of all shares of Common Stock beneficially owned by Stiefel. Charles W. Stiefel and Stiefel are referred to herein as the "Reporting Persons."
Documents
Issuer
BARRIER THERAPEUTICS INC
CIK 0001173657
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001173657
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 3:19 PM ET
- Size
- 7.8 KB